机构名称：
¥ 1.0
• The HLA must be tested on the blood • Tebentafusp-Tebn is administered under prolonged observation, generally for the first 3 doses • premedication can be taken into consideration during the initial doses, but often it is not necessary subsequently • Most of the side effects occurs during the initial doses and it is not probable that it leads to the suspension • CRS manifests itself in most patients;发烧通常是第一个信号•皮肤毒性（例如皮疹）在初始剂量中也更为常见，并且通常会随着时间的流逝而改善•由于低血压的风险，请考虑纠正>的皮质类固醇剂量的可能性。
tebentafusp-tebn，用于不可分离
主要关键词
相关文件推荐
